Htet Lin Aung

Dr. Htet Lin Aung

Harvard Medical School, Boston, Massachusetts, USA
+1
orcid
I am a dedicated medical professional with a dynamic career ...

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2025 in ScienceOpen Preprints
Verified
Preprint
Open access
Htet Lin AungHtet Lin Aung
Htet Lin Aung
HTHtay Thiri
Htay Thiri
NWNway Yee Win
Nway Yee Win
Health behaviors are influenced by culture, beliefs, and access to healthcare. Myanmar is a deeply spiritual and traditional location; therefore, health behavior needs to be understood through a cultural lens. This chapter discusses the health behavior influenced by culture and psychological models of health behavior including the Health Belief Model (HBM), and COM-B (Capability, Opportunity, Motivation—Behavior). The chapter is based on real world experience working in healthcare community in Myanmar and illustrates how cultural practices impact decisions to seek health care-including delaying care, complex relationships with hearing the health messages, and the continued importance upon individuals accepted practices that came from ancestors. A HBM is reviewed to demonstrate the beliefs about susceptibility and severity of being unwell or ill including the behavioral comprehend, perceived barriers, and self-efficacy to behave differently to seek care, and the COM-B model used for the areas of opportunities, and how (using the HBM and COM-B as an integrated model for guiding theory) capability and motivation were all used to alter attitudes and behaviors strategically for sustainable change through different community capacity building methods. Examples are provided including intervention examples or in real-life scenarios and local strategies through culturally sensitive language adaptation, and indirectly through community dialogue with traditional healers, storytelling, and culturally relevant education methods. The chapter ends with suggestions to use to promote the importance of integrating culturally competent care and traditional practices while incorporating evidence-based practices with implications intended for future projects.



21 March 2025 in Research Square
Verified
Preprint
Open access
PDF file
Htet Lin AungHtet Lin Aung
Htet Lin Aung
Background SARS-CoV-2, initially identified as a respiratory pathogen, has emerged as a significant driver of neurological morbidity in the post-acute phase of infection. A substantial body of evidence underscores persistent neuroimmune dysregulation, cerebrovascular injury, and cognitive impairment as critical contributors to long-term disability among COVID-19 survivors. However, the mechanistic interplay between these processes and their clinical implications remains incompletely characterized. Objectives This systematic review and meta-analysis aim to (1) elucidate the pathophysiological mechanisms underlying post-acute neurological outcomes of COVID-19, (2) evaluate the prevalence and clinical spectrum of neuroimmune, cerebrovascular, and cognitive disturbances using both qualitative and quantitative data, and (3) propose strategies for early detection and clinical management based on rigorous, evidence-based findings. Methods A comprehensive search of PubMed, EMBASE, and the Cochrane Library was conducted for studies published between January 1, 2020, and January 31, 2025. Included studies reported on neuroinflammatory biomarkers, cerebrovascular events, or cognitive dysfunction assessed ≥ 4 weeks after acute SARS-CoV-2 infection. Two independent reviewers screened records, extracted data, and appraised study quality using PRISMA 2020 guidelines. A narrative synthesis was supplemented by a quantitative meta-analysis of key outcomes, with pooled effect estimates calculated using random-effects models to address heterogeneity. Results From 2,178 screened records, 10 studies (n ≈ 77,300) met the inclusion criteria. Three interrelated pathological domains were identified: (1) Neuroimmune Dysregulation: Persistent cytokine elevations (e.g., IL-6, TNF-α), microglial activation, and neuronal autoantibodies (detected in ~ 18% of patients) indicate a state of chronic neuroinflammation. (2) Cerebrovascular Complications: A 3.7-fold increased risk of stroke, along with evidence of blood–brain barrier (BBB) disruption and microvascular injury, underscores the role of endothelial dysfunction and thromboinflammatory pathways. (3) Cognitive Dysfunction: Deficits in memory, executive function, and processing speed, reported in up to 58% of patients, correlated with neuroimaging findings of grey matter atrophy and altered functional connectivity. The meta-analysis yielded a pooled standardized mean difference for IL-6 elevation of 0.78 (95% CI: 0.55–1.01; p < 0.001) and a pooled odds ratio for stroke risk of 3.7 (95% CI: 2.1–6.4; p < 0.001). Moderate-to-high heterogeneity (I² between 50% and 70%) was addressed using random-effects models and sensitivity analyses, which confirmed the robustness of these associations. Conclusions Post-acute COVID-19 manifests as a triad of neuroimmune, vascular, and cognitive disturbances, supported by both narrative and quantitative analyses. Early identification through multimodal screening including advanced neuroimaging, comprehensive inflammatory biomarker profiling, and validated cognitive assessments are essential. Targeted therapeutic strategies focusing on endothelial stabilization and immunomodulation may prove pivotal in mitigating long-term disability. Future research should prioritize standardized outcome measures and mechanistic studies to further refine interventional approaches and inform clinical policy.

29 November 2025 in ScienceOpen Preprints
Verified
Preprint
Open access
Htet Lin AungHtet Lin Aung
Htet Lin Aung
KLKaung Wai Yan Lwin
Kaung Wai Yan Lwin
Artificial intelligence (AI) is rapidly transforming healthcare around the world with its greatest potential in low- and middle-income countries (LMICs), which face workforce shortages, long travel distances, and limited diagnostic capability. AI is an equalizing agent in resource-limited environments, reinforcing the obligation for safe and responsible use for both patients and healthcare workers as highlighted in this perspective. For instance, patients from rural areas can use AI-enabled medication checkers, to identify possible drug interactions, explain side effects, and provide reliable information about known illnesses—with strong disclaimers against self-diagnosis or self-medication. For healthcare workers, AI can create efficiency in workflow, assist in the review of radiologic findings, and support task-shifting in overburdened health systems. This perspective also emphasizes the importance of AI literacy, ethical guidelines, and free continuing professional education (CME) offered by governments and policymakers to support equitable and context appropriate use. Thus, AI can provide a useful, responsible, demonstrably helpful force multiplier, augmenting healthcare capacity, patient safety, and access to quality care in low- and middle-income countries while giving providers helpful advantages in systems where they face overwhelming constraints of time and expertise.

31 December 2024 in SSRN Electronic Journal
Verified
Preprint
Open access
Htet Lin AungHtet Lin Aung
Htet Lin Aung
Background: Autism Spectrum Disorder (ASD) affects individuals of all ages and backgrounds, yet misconceptions and stigma continue. Effective healthcare for individuals with ASD requires a patient-centered approach that addresses their unique medical, emotional, and social needs. This study surveyed caregivers of individuals with ASD in Myanmar, gathering insights about their healthcare experiences, communication, and unmet needs. These findings aim to inform strategies to improve care and promote inclusivity in the healthcare system. Objective: This study explores the healthcare experiences of caregivers of individuals with ASD in Myanmar. It identifies challenges in communication, support, and service delivery while highlighting gaps in current care strategies. By examining caregivers' perspectives, the study aims to offer insights that will help shape patient-centered care practices that address the medical, emotional, and social needs of individuals with ASD. The ultimate goal is to promote inclusive, empathetic healthcare that enhances long-term outcomes for both individuals with ASD and their families. Methodology: A survey-based approach was used to collect data from caregivers of individuals with ASD in Myanmar. The survey included structured questions designed to assess caregivers' experiences with healthcare services, communication practices, and the challenges they faced. Quantitative data were analyzed using descriptive statistics to identify trends, while qualitative responses were examined through thematic analysis to uncover recurring patterns and key insights. This mixed-methods approach provided a comprehensive understanding of the caregivers' experiences and highlighted areas for improvement in patient-centered care. Results: The survey revealed several challenges faced by caregivers of individuals with ASD in accessing and navigating healthcare. Quantitative data showed that a majority of respondents reported difficulties with communication between healthcare providers and patients. Many caregivers also expressed concerns about unmet needs related to sensory sensitivities and behavioral issues, which are common in individuals with ASD. The thematic analysis of qualitative responses further highlighted a lack of tailored care, insufficient provider training, and the need for greater caregiver involvement in decision-making. These findings underscore the importance of adopting inclusive, patient-centered care practices that consider both the medical and non-medical aspects of ASD care. Conclusion: Adopting a patient-centered care approach and utilizing the biopsychosocial model can significantly enhance care for individuals with ASD. By addressing the unique health challenges faced by individuals with ASD through empathy, communication, and collaboration, healthcare providers can offer more effective and inclusive treatment. The study highlights the need to better support caregivers and patients by providing tailored care that respects their experiences and individual needs. Additionally, reducing stigma and promoting understanding about ASD are essential for improving long-term health outcomes and the overall quality of life for individuals with ASD. Ultimately, the findings emphasize the importance of fostering an inclusive, compassionate healthcare environment that supports both patients and their families.